V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

STAAR Surgical Executive Compensation (FY25)

STAA · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): June 22, 2026
221 figures on this page: 210 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
Stephen Farrell, Chief Executive Officer, received $7,522,385 in total compensation for fiscal 2025. Meanwhile, for fiscal 2025, shareholders backed the say-on-pay proposal with 96.3% of votes cast including abstentions in favor at the meeting held June 18, 2026. Separately, for fiscal 2025, the company reported a chief executive pay ratio of 97:1, against median employee compensation of $89,344, and companies named in the disclosed peer group include Alphatec Holdings, Inc., Artivion, Inc., AtriCure, Inc., Avanos Medical, Inc. and AxoGen, Inc., among others. The fiscal 2025 disclosure covers 7 named executive officers.
Chief executive, fiscal 2025
◇
Stephen Farrell
Median of the other named officers
$2,639,082
6 officers, excluding the chief executive
Latest say-on-pay support
=
June 18, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Thomas Frinzi → Stephen Farrell
CEO pay ratio: 95:1 → 97:1 (2.1% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is STAAR Surgical's chief executive and what were they paid?
Stephen Farrell, Chief Executive Officer, received $7,522,385 in total compensation for fiscal 2025.
What was STAAR Surgical's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 96.3% of votes cast including abstentions in favor at the meeting held June 18, 2026.
Which companies are in STAAR Surgical's peer group?
Companies named in the disclosed peer group include Alphatec Holdings, Inc., Artivion, Inc., AtriCure, Inc., Avanos Medical, Inc. and AxoGen, Inc., among others.
What is STAAR Surgical's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 97:1, against median employee compensation of $89,344.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Frinzi
Former President and Chief Executive Officer
◇—◇◇◇—◇◇
Warren Foust
President and Chief Operating Officer
◇—◇◇◇—◇◇
Patrick Williams
Former Chief Financial Officer
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Frinzi
President and Chief Executive Officer
◇—◇◇——◇◇
Warren Foust
Chief Operating Officer
◇—◇◇——◇◇
Patrick Williams
Chief Financial Officer
◇—◇◇——◇◇
Magda Michna
Chief Clinical, Regulatory and Medical Affairs Officer
◇◇◇◇——◇◇
Nathaniel Sisitsky
General Counsel and Corporate Secretary
◇—◇◇——◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Stephen Farrell
Chief Executive Officer
◇—◇———◇◇
Warren Foust
President and Chief Operating Officer
◇◇◇—◇—◇◇
Nathaniel Sisitsky
Chief Legal Officer and Corporate Secretary
◇◇◇—◇—◇◇
Magda Michna
Chief Development Officer
◇—◇—◇—◇◇
Deborah Andrews
Chief Financial Officer
◇—◇—◇—◇◇
Thomas Frinzi
Former President and Chief Executive Officer
Departed during or after this year
◇—————◇◇
Patrick Williams
Former Chief Financial Officer
Departed during or after this year
◇—————◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Deborah AndrewsPSU◇—◇—◇—◇
Magda MichnaRSU◇——◇——◇
Nathaniel SisitskyRSU◇——◇——◇
Stephen C. FarrellRSU◇——◇——◇
Warren FoustRSU◇——◇——◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Warren FoustOption◇—◇3/11/2034
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇5/7/2033
Nathaniel SisitskyRSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Option◇—◇12/10/2033
Option◇—◇3/11/2034
Magda MichnaRSU◇◇——
PSU◇◇——
RSU◇◇——
Option◇—◇3/11/2034
Option◇—◇5/7/2033
RSU◇◇——
Thomas FrinziRSU◇◇——
RSU◇◇——
Deborah AndrewsRSU◇◇——
PSU◇◇——
Stephen FarrellPSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Wei Jiang
◇◇———◇◇
Lilian Y. Zhou
◇—◇——◇◇
Elizabeth Yeu, M.D
◇◇◇———◇
Louis E. Silverman
◇◇◇———◇
Arthur C. Butcher
◇◇◇———◇
Aimee S. Weisner
◇—————◇
Neal C. Bradsher, K. Peony Yu, M.D, Richard T. LeBuhn, Stephen C. Farrell, Thomas G. Frinzi and Christopher M. Wang served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as Restricted Stock or Stock Options (director's choice).
Stock ownership guideline: 3x base annual cash retainer (directors); 3x annual base salary (CEO)

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alphatec Holdings, Inc. ATEC
  • Artivion, Inc. AORT
  • AtriCure, Inc. ATRC
  • Avanos Medical, Inc. AVNS
  • AxoGen, Inc. AXGN
  • Glaukos Corp. GKOS
  • Inari Medical, Inc. NARI
  • Inspire Medical Systems, Inc. INSP
  • iRhythm Technologies, Inc. IRTC
  • LeMaitre Vascular, Inc. LMAT
  • Merit Medical Systems, Inc. MMSI
  • Penumbra, Inc. PEN
  • RxSight, Inc. RXST
  • Tandem Diabetes Care, Inc. TNDM
  • UFP Technologies, Inc. UFPT

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 18, 2026=◇◇◇
2024June 18, 2025=◇◇◇
2023June 20, 2024=◇◇◇
2022June 15, 2023=◇◇◇
2021June 16, 2022=◇◇◇
2020June 24, 2021=◇◇◇
2019July 30, 2020=◇◇◇
2018June 20, 2019=◇◇◇
2017June 14, 2018=◇◇◇
2016June 13, 2017=◇◇◇
2015June 24, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when STAAR Surgical files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact STAAR Surgical disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where STAAR Surgical sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether STAAR Surgical's disclosed peer group is defensible, who names STAAR Surgical back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
221 figures on this page: 210 cited to the filing that reported them, 11 calculated from figures it prints.
210 cited to the filing
11 calculated from the filing

Documents cited

  1. 0000718937-26-000029
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0000718937-26-000015
    2025 Director Compensation · CEO Pay Ratio · COMPENSATION OF DIRECTORS · Compensation of Directors · and 2 more sections
  3. 0000950170-25-087967
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000950170-25-058174
    Summary Compensation Table
  5. 0000950170-24-076303
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000950170-24-047635
    Summary Compensation Table
  7. 0000950170-23-028687
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001564590-22-023566
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001564590-21-034584
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001564590-20-035237
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001564590-19-023002
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0001144204-18-034262
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0001144204-17-032385
    Item 5.07 Submission of Matters to a Vote of Security Holders
  14. 0001144204-16-109967
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “STAAR Surgical executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/STAA (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about STAAR Surgical and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers STAAR Surgical discloses

The companies named in STAA's own disclosed peer group.

Artivion, Inc.AtriCure, Inc.Avanos Medical, Inc.AxoGen, Inc.Glaukos Corp.Inspire Medical Systems, Inc.iRhythm Technologies, Inc.LeMaitre Vascular, Inc.Merit Medical Systems, Inc.Penumbra, Inc.RxSight, Inc.Tandem Diabetes Care, Inc.UFP Technologies, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy